DRREDDY / FY26 summary

The year in one view.

Dr. Reddy's Laboratories · annual summary assembled from the available FY26 source records.

Research layer active

Revenue across quarters

94,164

₹ Cr where applicable

PAT across quarters

15,477

₹ Cr where applicable

Source quarters

12

₹ Cr where applicable

EBITDA (₹ Cr)PositiveWatchNegative
12 actual records
Actual quarterly EBITDA (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q1 FY24: 2,137 · Positive source sentiment · 2023-07-26Q1 FY24Q2 FY24: 2,181 · Positive source sentiment · 2023-10-25Q2 FY24Q3 FY24: 2,111 · Positive source sentiment · 2024-01-24Q3 FY24Q4 FY24: 1,872 · Positive source sentiment · 2024-05-08Q4 FY24Q1 FY25: 2,160 · Positive source sentiment · 2024-07-24Q1 FY25Q2 FY25: 2,280 · Positive source sentiment · 2024-10-23Q2 FY25Q3 FY25: 2,298 · Watch source sentiment · 2025-01-22Q3 FY25Q4 FY25: 2,475 · Positive source sentiment · 2025-04-30Q4 FY25Q1 FY26: 2,278 · Watch source sentiment · 2025-07-30Q1 FY26Q2 FY26: 2,351 · Watch source sentiment · 2025-10-28Q2 FY26Q3 FY26: 2,049 · Watch source sentiment · 2026-01-23Q3 FY26Q4 FY26: 1,554 · Watch source sentiment · 2026-04-??Q4 FY262,4751,554
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.